Quality assurance in neuropathology: experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019 - Riemenschneider, Markus Johannes; Fischer, Josephine; Grassow-Narlik, Maja; Mawrin, Christian; Deimling, Andreas von; Pietsch, Torsten; Reifenberger, Guido; Müller, Wolf C.; Sommer, Clemens; Dietel, Manfred; Zoubaa, Saida; Lorenz, Julia; et al. (Clinical neuropathology, 2020)
Gesehen am 29.09.2020